2-Deoxy-D-glucose (2-DG), a well-known inhibitor of glycolysis, sensitizes tumor cells to ADR and PTX in human osteosarcoma and NSCLC by suppressing HK2 expression [164]. This evidence concerns the gene HK2 and neoplasm.